Back to Atlas
aganitha.ai·Tracked since May 27, 2026

Aganitha

Mentions

1

Across all reports

Quality Score

15/ 100

New

First Seen

May 27, 2026

Indexed in atlas

Last Seen

3h ago

Most recent reference

Positioning

Synthesized from 1 mention

Aganitha offers an AI platform that screens millions of molecules for properties like binding affinity. They focus on speed and accuracy using deep learning. Pricing is subscription-based, likely $50k-$100k/year. They also provide consulting services.

Strengths

3 cited
  • AI-first approach
  • Fast screening
  • Cloud-based

Weaknesses

3 cited
  • New entrant
  • Limited validation
  • Small team

Recent mentions

Showing 1 of 1
  • direct
    3h ago

    Virtual Screening Platform for Drug Discovery Teams

    virtualscreeningplatformdrugdiscoveryteams

Validate something like Aganitha

Use Aganitha as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.